Hot Features
プレミアム
Syros Pharmaceuticals Inc (SYRS)
NASDAQ
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and ... Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States. 詳細を表示
-- SELECT-MDS-1 Did Not Meet its Primary Endpoint -- -- Company to Discontinue Study, Review Full Data Set, and Evaluate Next Steps -- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical...
-- Pivotal Complete Response (CR) Data from SELECT-MDS-1 Phase 3 Trial Expected in Mid-November -- -- Management to Host Conference Call at 8:30 AM ET Today -- Syros Pharmaceuticals (NASDAQ:...
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.07 | -84.4897959184 | 2.45 | 3.4 | 0.1569 | 408785 | 2.88167285 | CS |
| 4 | -1.61 | -80.9045226131 | 1.99 | 3.4 | 0.1569 | 525523 | 2.41839731 | CS |
| 12 | -1.32 | -77.6470588235 | 1.7 | 3.4 | 0.1569 | 332333 | 2.15293122 | CS |
| 26 | -4.6 | -92.3694779116 | 4.98 | 6.9275 | 0.1569 | 268650 | 2.78181071 | CS |
| 52 | -2.34 | -86.0294117647 | 2.72 | 8.17 | 0.1569 | 256960 | 4.16974641 | CS |
| 156 | -3.78 | -90.8653846154 | 4.16 | 8.17 | 0.1569 | 372991 | 2.23394199 | CS |
| 260 | -4.74 | -92.578125 | 5.12 | 15.6499 | 0.1569 | 464170 | 5.04921281 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
